Review



human cd40 ligand cd40l multimer kit  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Miltenyi Biotec human cd40 ligand cd40l multimer kit
    Human Cd40 Ligand Cd40l Multimer Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+multimer/pmc12433645-86-26-31?v=Miltenyi+Biotec
    Average 93 stars, based on 9 article reviews
    human cd40 ligand cd40l multimer kit - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    93
    Miltenyi Biotec human cd40 ligand cd40l multimer kit
    Human Cd40 Ligand Cd40l Multimer Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+multimer/pmc12433645-86-26-31?v=Miltenyi+Biotec
    Average 93 stars, based on 1 article reviews
    human cd40 ligand cd40l multimer kit - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec human cd40l multimer
    Human Cd40l Multimer, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+multimer/pm40614737-430-6-11?v=Miltenyi+Biotec
    Average 93 stars, based on 1 article reviews
    human cd40l multimer - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec human cd40l multimer kit
    ( A ) Splenocytes of WT mice challenged with 16.113 TAg + cancer cells were stimulated with peptide IV at indicated time points. d, day. The dot plots show the intracellular IFN-γ and <t>CD40L</t> staining of CD3 + CD8 + CD4 − -gated lymphocytes from one representative mouse ( n = 4 mice). ( B ) The diagram summarizes the frequencies of CD40L + IFN-γ + and CD40L − IFN-γ + CD8 + T cells and ( C ) the frequency of IL-2–producing cells among CD40L + and CD40L − tumor-specific CD8 + T cells at the different time points (both means ± SD).
    Human Cd40l Multimer Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+multimer/pmc12094236-181-18-24?v=Miltenyi+Biotec
    Average 93 stars, based on 1 article reviews
    human cd40l multimer kit - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec multimeric cd40l
    ( A ) Splenocytes of WT mice challenged with 16.113 TAg + cancer cells were stimulated with peptide IV at indicated time points. d, day. The dot plots show the intracellular IFN-γ and <t>CD40L</t> staining of CD3 + CD8 + CD4 − -gated lymphocytes from one representative mouse ( n = 4 mice). ( B ) The diagram summarizes the frequencies of CD40L + IFN-γ + and CD40L − IFN-γ + CD8 + T cells and ( C ) the frequency of IL-2–producing cells among CD40L + and CD40L − tumor-specific CD8 + T cells at the different time points (both means ± SD).
    Multimeric Cd40l, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+multimer/pmc12094236-191-36-40?v=Miltenyi+Biotec
    Average 93 stars, based on 1 article reviews
    multimeric cd40l - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec human recombinant cd40l
    ( A ) Splenocytes of WT mice challenged with 16.113 TAg + cancer cells were stimulated with peptide IV at indicated time points. d, day. The dot plots show the intracellular IFN-γ and <t>CD40L</t> staining of CD3 + CD8 + CD4 − -gated lymphocytes from one representative mouse ( n = 4 mice). ( B ) The diagram summarizes the frequencies of CD40L + IFN-γ + and CD40L − IFN-γ + CD8 + T cells and ( C ) the frequency of IL-2–producing cells among CD40L + and CD40L − tumor-specific CD8 + T cells at the different time points (both means ± SD).
    Human Recombinant Cd40l, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+multimer/pm40199608-32-36-39?v=Miltenyi+Biotec
    Average 93 stars, based on 1 article reviews
    human recombinant cd40l - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec cd40l
    ( A ) Splenocytes of WT mice challenged with 16.113 TAg + cancer cells were stimulated with peptide IV at indicated time points. d, day. The dot plots show the intracellular IFN-γ and <t>CD40L</t> staining of CD3 + CD8 + CD4 − -gated lymphocytes from one representative mouse ( n = 4 mice). ( B ) The diagram summarizes the frequencies of CD40L + IFN-γ + and CD40L − IFN-γ + CD8 + T cells and ( C ) the frequency of IL-2–producing cells among CD40L + and CD40L − tumor-specific CD8 + T cells at the different time points (both means ± SD).
    Cd40l, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+multimer/pmc10880039-826-10-11?v=Miltenyi+Biotec
    Average 93 stars, based on 1 article reviews
    cd40l - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Splenocytes of WT mice challenged with 16.113 TAg + cancer cells were stimulated with peptide IV at indicated time points. d, day. The dot plots show the intracellular IFN-γ and CD40L staining of CD3 + CD8 + CD4 − -gated lymphocytes from one representative mouse ( n = 4 mice). ( B ) The diagram summarizes the frequencies of CD40L + IFN-γ + and CD40L − IFN-γ + CD8 + T cells and ( C ) the frequency of IL-2–producing cells among CD40L + and CD40L − tumor-specific CD8 + T cells at the different time points (both means ± SD).

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) Splenocytes of WT mice challenged with 16.113 TAg + cancer cells were stimulated with peptide IV at indicated time points. d, day. The dot plots show the intracellular IFN-γ and CD40L staining of CD3 + CD8 + CD4 − -gated lymphocytes from one representative mouse ( n = 4 mice). ( B ) The diagram summarizes the frequencies of CD40L + IFN-γ + and CD40L − IFN-γ + CD8 + T cells and ( C ) the frequency of IL-2–producing cells among CD40L + and CD40L − tumor-specific CD8 + T cells at the different time points (both means ± SD).

    Article Snippet: Depletion of caspase-8 and sensitivity to CD40-mediated cell death were analyzed after stimulation of generated cell lines with human CD40L multimer kit (10 μg/ml; Miltenyi Biotec) for 48 hours, and caspase-8 initiation was detected as described above.

    Techniques: Staining

    ( A ) RAG1 −/− mice were injected subcutaneously with 1 × 10 6 9.27 TAg + cancer cells and treated in parallel with intravenously injected CD8 + T cells from WT or CD40L −/− mice and/or with WT CD4 + T cells. The means ± SD of the tumor size of four or five mice per group are shown from one representative of five experiments. ( B ) The tumor sizes of individual mice in different groups are shown at day 26. ( C ) Summary of the tumor formation data obtained from five independent experiments. Tumor formation was defined as an established tumor when its volume reached >500 mm 3 . Statistical analysis: Analysis of variance (ANOVA) with Bonferroni multiple comparisons posttest: * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) RAG1 −/− mice were injected subcutaneously with 1 × 10 6 9.27 TAg + cancer cells and treated in parallel with intravenously injected CD8 + T cells from WT or CD40L −/− mice and/or with WT CD4 + T cells. The means ± SD of the tumor size of four or five mice per group are shown from one representative of five experiments. ( B ) The tumor sizes of individual mice in different groups are shown at day 26. ( C ) Summary of the tumor formation data obtained from five independent experiments. Tumor formation was defined as an established tumor when its volume reached >500 mm 3 . Statistical analysis: Analysis of variance (ANOVA) with Bonferroni multiple comparisons posttest: * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Article Snippet: Depletion of caspase-8 and sensitivity to CD40-mediated cell death were analyzed after stimulation of generated cell lines with human CD40L multimer kit (10 μg/ml; Miltenyi Biotec) for 48 hours, and caspase-8 initiation was detected as described above.

    Techniques: Injection

    ( A ) Strategy for the generation of CD40L fl/fl mice. UTR, untranslated region; FRT, flippase recognition target. ( B ) E8I-Cre × CD40L fl/fl , E8I-Cre, and CD40L fl/fl mice as WT control were injected subcutaneously with 1 × 10 6 9.27 TAg + cancer cells. Summary of the tumor formation data obtained from three individual experiments, each with 5 to 10 mice per group. Tumor was defined as established when its volume reached >500 mm 3 . ( C and D ) WT and E8I-Cre × CD40L fl/fl mice were subcutaneously injected with 1 × 10 6 9.27 TAg + cancer cells, and 7 days later, splenocytes and cells from the draining lymph nodes (dLNs) were isolated and stimulated with peptide IV. (C) The dot plots show the intracellular IFN-γ and CD40L staining of CD3 + CD8 + CD4 − -gated splenocytes from one representative mouse of five mice. (D) The diagram summarizes the frequencies of TAg-specific IFN-γ + CD8 + T cells measured among splenocytes and lymph node cells. Statistical analysis: Log-rank test: ** P < 0.01.

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) Strategy for the generation of CD40L fl/fl mice. UTR, untranslated region; FRT, flippase recognition target. ( B ) E8I-Cre × CD40L fl/fl , E8I-Cre, and CD40L fl/fl mice as WT control were injected subcutaneously with 1 × 10 6 9.27 TAg + cancer cells. Summary of the tumor formation data obtained from three individual experiments, each with 5 to 10 mice per group. Tumor was defined as established when its volume reached >500 mm 3 . ( C and D ) WT and E8I-Cre × CD40L fl/fl mice were subcutaneously injected with 1 × 10 6 9.27 TAg + cancer cells, and 7 days later, splenocytes and cells from the draining lymph nodes (dLNs) were isolated and stimulated with peptide IV. (C) The dot plots show the intracellular IFN-γ and CD40L staining of CD3 + CD8 + CD4 − -gated splenocytes from one representative mouse of five mice. (D) The diagram summarizes the frequencies of TAg-specific IFN-γ + CD8 + T cells measured among splenocytes and lymph node cells. Statistical analysis: Log-rank test: ** P < 0.01.

    Article Snippet: Depletion of caspase-8 and sensitivity to CD40-mediated cell death were analyzed after stimulation of generated cell lines with human CD40L multimer kit (10 μg/ml; Miltenyi Biotec) for 48 hours, and caspase-8 initiation was detected as described above.

    Techniques: Control, Injection, Isolation, Staining

    ( A ) CD40L −/− and CD40 −/- mice were injected subcutaneously with 1 × 10 6 9.27 cancer cells. Summary of the tumor formation data obtained from two individual experiments, each with 6 to 10 mice per group. Tumor was defined as established when its volume reached >500 mm 3 . FSC-A, forward-scatter-area. ( B ) Cell surface expression of CD40 was analyzed after culturing 9.27 cancer cells, supplemented with or without TGFβ for 24 hours in three individual experiments. ( C and D ) The 9.27 cancer cells were treated for 24 hours with TGFβ and subsequently stimulated for further 24 hours with multimeric mouse CD40L. Thereafter, caspase-8 activity was determined with the fluorescence marker FITC-IETD-FMK and costained with annexin V. (C) The representative dot plots show the gating of annexin V and FITC-IETD-FMK–stained cancer cells after triggering CD40. (D) The diagrams summarize the frequencies of active caspase-8 + cancer cells, measured as triplicates of one of three representative experiments.

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) CD40L −/− and CD40 −/- mice were injected subcutaneously with 1 × 10 6 9.27 cancer cells. Summary of the tumor formation data obtained from two individual experiments, each with 6 to 10 mice per group. Tumor was defined as established when its volume reached >500 mm 3 . FSC-A, forward-scatter-area. ( B ) Cell surface expression of CD40 was analyzed after culturing 9.27 cancer cells, supplemented with or without TGFβ for 24 hours in three individual experiments. ( C and D ) The 9.27 cancer cells were treated for 24 hours with TGFβ and subsequently stimulated for further 24 hours with multimeric mouse CD40L. Thereafter, caspase-8 activity was determined with the fluorescence marker FITC-IETD-FMK and costained with annexin V. (C) The representative dot plots show the gating of annexin V and FITC-IETD-FMK–stained cancer cells after triggering CD40. (D) The diagrams summarize the frequencies of active caspase-8 + cancer cells, measured as triplicates of one of three representative experiments.

    Article Snippet: Depletion of caspase-8 and sensitivity to CD40-mediated cell death were analyzed after stimulation of generated cell lines with human CD40L multimer kit (10 μg/ml; Miltenyi Biotec) for 48 hours, and caspase-8 initiation was detected as described above.

    Techniques: Injection, Expressing, Activity Assay, Fluorescence, Marker, Staining

    ( A ) Cell surface expression of CD40 was analyzed after culturing TRAMP-C1 and CD40 tg TRAMP-C1 cells with or without TGFβ for 24 hours. ( B ) Both TRAMP-C1 cancer cell lines were stimulated for 24 hours with multimeric CD40L. Thereafter, caspase-8 activity was determined with the fluorescence marker FITC-IETD-FMK. The representative dot plots show the gating of 4′,6-diamidino-2-phenylindole (DAPI) and FITC-IETD-FMK–stained cancer cells after triggering CD40. The diagrams summarize the frequencies of active caspase-8 + cancer cells. ( C and D ) E8I-Cre × CD40L fl/fl and E8I-Cre as WT control mice were injected subcutaneously with 5 × 10 6 TRAMP-C1 (C) or CD40 tg TRAMP-C1 (D) cancer cells. In the diagrams [(C) and (D)], the data from one of two representative experiments are shown. Per group, five or six mice were challenged. Tumor was defined as established when its volume reached >500 mm 3 . Statistical analysis: (B) Mann-Whitney U test: ** P < 0.01 and [(C) and (D)] log-rank test: * P < 0.05 and ** P < 0.01.

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) Cell surface expression of CD40 was analyzed after culturing TRAMP-C1 and CD40 tg TRAMP-C1 cells with or without TGFβ for 24 hours. ( B ) Both TRAMP-C1 cancer cell lines were stimulated for 24 hours with multimeric CD40L. Thereafter, caspase-8 activity was determined with the fluorescence marker FITC-IETD-FMK. The representative dot plots show the gating of 4′,6-diamidino-2-phenylindole (DAPI) and FITC-IETD-FMK–stained cancer cells after triggering CD40. The diagrams summarize the frequencies of active caspase-8 + cancer cells. ( C and D ) E8I-Cre × CD40L fl/fl and E8I-Cre as WT control mice were injected subcutaneously with 5 × 10 6 TRAMP-C1 (C) or CD40 tg TRAMP-C1 (D) cancer cells. In the diagrams [(C) and (D)], the data from one of two representative experiments are shown. Per group, five or six mice were challenged. Tumor was defined as established when its volume reached >500 mm 3 . Statistical analysis: (B) Mann-Whitney U test: ** P < 0.01 and [(C) and (D)] log-rank test: * P < 0.05 and ** P < 0.01.

    Article Snippet: Depletion of caspase-8 and sensitivity to CD40-mediated cell death were analyzed after stimulation of generated cell lines with human CD40L multimer kit (10 μg/ml; Miltenyi Biotec) for 48 hours, and caspase-8 initiation was detected as described above.

    Techniques: Expressing, Activity Assay, Fluorescence, Marker, Staining, Control, Injection, MANN-WHITNEY

    ( A ) Histograms represent the CD40 expression on EJ138 or A704 transfected with nontargeting single guide RNA (black, sgNon) or cells depleted for CD40 by CRISPR-Cas9 and sgRNA against human CD40 (red). Gray-filled histograms show isotype staining. ( B ) sgNon (black) or caspase-8 sgRNA–treated (red) EJ138 and A704 cells were treated with multimeric CD40L for 24 hours, and caspase-8 activation was monitored by FITC-IETD-FMK staining. Gray-filled histograms represent the basal caspase-8 activation of unstimulated WT cells. ( C and D ) sgNon, CD40 sgRNA-, or caspase-8 (Casp8) sgRNA–treated variants of EJ138 (C) or A704 (D) were cocultivated with CD40L-enriched CD8 + T cells for 24 hours, and apoptosis was detected by annexin V and DAPI staining. Shown are representative dot plots with frequencies of technical triplicates (left) and bar graphs summarizing the data from experiments with eight different T cell donors. Statistical analysis: [(C) and (D)] Repeated measures ANOVA, followed by Dunnett’s test: ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) Histograms represent the CD40 expression on EJ138 or A704 transfected with nontargeting single guide RNA (black, sgNon) or cells depleted for CD40 by CRISPR-Cas9 and sgRNA against human CD40 (red). Gray-filled histograms show isotype staining. ( B ) sgNon (black) or caspase-8 sgRNA–treated (red) EJ138 and A704 cells were treated with multimeric CD40L for 24 hours, and caspase-8 activation was monitored by FITC-IETD-FMK staining. Gray-filled histograms represent the basal caspase-8 activation of unstimulated WT cells. ( C and D ) sgNon, CD40 sgRNA-, or caspase-8 (Casp8) sgRNA–treated variants of EJ138 (C) or A704 (D) were cocultivated with CD40L-enriched CD8 + T cells for 24 hours, and apoptosis was detected by annexin V and DAPI staining. Shown are representative dot plots with frequencies of technical triplicates (left) and bar graphs summarizing the data from experiments with eight different T cell donors. Statistical analysis: [(C) and (D)] Repeated measures ANOVA, followed by Dunnett’s test: ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Article Snippet: Depletion of caspase-8 and sensitivity to CD40-mediated cell death were analyzed after stimulation of generated cell lines with human CD40L multimer kit (10 μg/ml; Miltenyi Biotec) for 48 hours, and caspase-8 initiation was detected as described above.

    Techniques: Expressing, Transfection, CRISPR, Staining, Activation Assay

    ( A ) In the histograms, the dark gray areas display the CD40 expression, and the light gray areas display the corresponding isotype control on eight different RCC lines. The included numbers represent the mean fluorescence intensity fold change between CD40 and isotype control staining. ( B ) Percentages of CD40L-induced lysis per RCC line after stimulation for 48 hours are plotted. Representative lysis values after backgorund substraction of each cell line of at least three individual experiments are depicted. ( C ) The heatmap represents the top 10 differentially expressed genes between CD40-resistant and CD40-sensitive RCC cell lines. ( D ) In the Kaplan-Meier survival plot, the resistance score of low and high groups of the TCGA-KIRC patient cohort is compared with each other. ( E ) Partial correlation networks of different patient groups are displayed, and the numbers are the partial correlation coefficients. ( F ) In the Kaplan-Meier survival plots, the resistance score of low and high groups of the cohorts is compared with all patients treated within the checkmate-009, checkmate-010, and checkmate-025 studies (left) or divided into two arms of the checkmate-025 study (middle nivolumab arm and right everolimus arm). Statistical analysis: (C) Described in Materials and Methods; [(D) and (F)] log-rank test.

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) In the histograms, the dark gray areas display the CD40 expression, and the light gray areas display the corresponding isotype control on eight different RCC lines. The included numbers represent the mean fluorescence intensity fold change between CD40 and isotype control staining. ( B ) Percentages of CD40L-induced lysis per RCC line after stimulation for 48 hours are plotted. Representative lysis values after backgorund substraction of each cell line of at least three individual experiments are depicted. ( C ) The heatmap represents the top 10 differentially expressed genes between CD40-resistant and CD40-sensitive RCC cell lines. ( D ) In the Kaplan-Meier survival plot, the resistance score of low and high groups of the TCGA-KIRC patient cohort is compared with each other. ( E ) Partial correlation networks of different patient groups are displayed, and the numbers are the partial correlation coefficients. ( F ) In the Kaplan-Meier survival plots, the resistance score of low and high groups of the cohorts is compared with all patients treated within the checkmate-009, checkmate-010, and checkmate-025 studies (left) or divided into two arms of the checkmate-025 study (middle nivolumab arm and right everolimus arm). Statistical analysis: (C) Described in Materials and Methods; [(D) and (F)] log-rank test.

    Article Snippet: Depletion of caspase-8 and sensitivity to CD40-mediated cell death were analyzed after stimulation of generated cell lines with human CD40L multimer kit (10 μg/ml; Miltenyi Biotec) for 48 hours, and caspase-8 initiation was detected as described above.

    Techniques: Expressing, Control, Fluorescence, Staining, Lysis

    ( A ) Splenocytes of WT mice challenged with 16.113 TAg + cancer cells were stimulated with peptide IV at indicated time points. d, day. The dot plots show the intracellular IFN-γ and CD40L staining of CD3 + CD8 + CD4 − -gated lymphocytes from one representative mouse ( n = 4 mice). ( B ) The diagram summarizes the frequencies of CD40L + IFN-γ + and CD40L − IFN-γ + CD8 + T cells and ( C ) the frequency of IL-2–producing cells among CD40L + and CD40L − tumor-specific CD8 + T cells at the different time points (both means ± SD).

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) Splenocytes of WT mice challenged with 16.113 TAg + cancer cells were stimulated with peptide IV at indicated time points. d, day. The dot plots show the intracellular IFN-γ and CD40L staining of CD3 + CD8 + CD4 − -gated lymphocytes from one representative mouse ( n = 4 mice). ( B ) The diagram summarizes the frequencies of CD40L + IFN-γ + and CD40L − IFN-γ + CD8 + T cells and ( C ) the frequency of IL-2–producing cells among CD40L + and CD40L − tumor-specific CD8 + T cells at the different time points (both means ± SD).

    Article Snippet: Subsequently, 5 × 10 4 cancer cells were plated in 96-well flat-bottom plates in phenol red–free DMEM supplemented with 1% FBS (Merck), penicillin (100 U/ml), and streptomycin (0.1 mg/ml; PAA) and cultured with or without human multimeric CD40L (10 μg/ml; Miltenyi Biotec) for 48 hours.

    Techniques: Staining

    ( A ) RAG1 −/− mice were injected subcutaneously with 1 × 10 6 9.27 TAg + cancer cells and treated in parallel with intravenously injected CD8 + T cells from WT or CD40L −/− mice and/or with WT CD4 + T cells. The means ± SD of the tumor size of four or five mice per group are shown from one representative of five experiments. ( B ) The tumor sizes of individual mice in different groups are shown at day 26. ( C ) Summary of the tumor formation data obtained from five independent experiments. Tumor formation was defined as an established tumor when its volume reached >500 mm 3 . Statistical analysis: Analysis of variance (ANOVA) with Bonferroni multiple comparisons posttest: * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) RAG1 −/− mice were injected subcutaneously with 1 × 10 6 9.27 TAg + cancer cells and treated in parallel with intravenously injected CD8 + T cells from WT or CD40L −/− mice and/or with WT CD4 + T cells. The means ± SD of the tumor size of four or five mice per group are shown from one representative of five experiments. ( B ) The tumor sizes of individual mice in different groups are shown at day 26. ( C ) Summary of the tumor formation data obtained from five independent experiments. Tumor formation was defined as an established tumor when its volume reached >500 mm 3 . Statistical analysis: Analysis of variance (ANOVA) with Bonferroni multiple comparisons posttest: * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Article Snippet: Subsequently, 5 × 10 4 cancer cells were plated in 96-well flat-bottom plates in phenol red–free DMEM supplemented with 1% FBS (Merck), penicillin (100 U/ml), and streptomycin (0.1 mg/ml; PAA) and cultured with or without human multimeric CD40L (10 μg/ml; Miltenyi Biotec) for 48 hours.

    Techniques: Injection

    ( A ) Strategy for the generation of CD40L fl/fl mice. UTR, untranslated region; FRT, flippase recognition target. ( B ) E8I-Cre × CD40L fl/fl , E8I-Cre, and CD40L fl/fl mice as WT control were injected subcutaneously with 1 × 10 6 9.27 TAg + cancer cells. Summary of the tumor formation data obtained from three individual experiments, each with 5 to 10 mice per group. Tumor was defined as established when its volume reached >500 mm 3 . ( C and D ) WT and E8I-Cre × CD40L fl/fl mice were subcutaneously injected with 1 × 10 6 9.27 TAg + cancer cells, and 7 days later, splenocytes and cells from the draining lymph nodes (dLNs) were isolated and stimulated with peptide IV. (C) The dot plots show the intracellular IFN-γ and CD40L staining of CD3 + CD8 + CD4 − -gated splenocytes from one representative mouse of five mice. (D) The diagram summarizes the frequencies of TAg-specific IFN-γ + CD8 + T cells measured among splenocytes and lymph node cells. Statistical analysis: Log-rank test: ** P < 0.01.

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) Strategy for the generation of CD40L fl/fl mice. UTR, untranslated region; FRT, flippase recognition target. ( B ) E8I-Cre × CD40L fl/fl , E8I-Cre, and CD40L fl/fl mice as WT control were injected subcutaneously with 1 × 10 6 9.27 TAg + cancer cells. Summary of the tumor formation data obtained from three individual experiments, each with 5 to 10 mice per group. Tumor was defined as established when its volume reached >500 mm 3 . ( C and D ) WT and E8I-Cre × CD40L fl/fl mice were subcutaneously injected with 1 × 10 6 9.27 TAg + cancer cells, and 7 days later, splenocytes and cells from the draining lymph nodes (dLNs) were isolated and stimulated with peptide IV. (C) The dot plots show the intracellular IFN-γ and CD40L staining of CD3 + CD8 + CD4 − -gated splenocytes from one representative mouse of five mice. (D) The diagram summarizes the frequencies of TAg-specific IFN-γ + CD8 + T cells measured among splenocytes and lymph node cells. Statistical analysis: Log-rank test: ** P < 0.01.

    Article Snippet: Subsequently, 5 × 10 4 cancer cells were plated in 96-well flat-bottom plates in phenol red–free DMEM supplemented with 1% FBS (Merck), penicillin (100 U/ml), and streptomycin (0.1 mg/ml; PAA) and cultured with or without human multimeric CD40L (10 μg/ml; Miltenyi Biotec) for 48 hours.

    Techniques: Control, Injection, Isolation, Staining

    ( A ) CD40L −/− and CD40 −/- mice were injected subcutaneously with 1 × 10 6 9.27 cancer cells. Summary of the tumor formation data obtained from two individual experiments, each with 6 to 10 mice per group. Tumor was defined as established when its volume reached >500 mm 3 . FSC-A, forward-scatter-area. ( B ) Cell surface expression of CD40 was analyzed after culturing 9.27 cancer cells, supplemented with or without TGFβ for 24 hours in three individual experiments. ( C and D ) The 9.27 cancer cells were treated for 24 hours with TGFβ and subsequently stimulated for further 24 hours with multimeric mouse CD40L. Thereafter, caspase-8 activity was determined with the fluorescence marker FITC-IETD-FMK and costained with annexin V. (C) The representative dot plots show the gating of annexin V and FITC-IETD-FMK–stained cancer cells after triggering CD40. (D) The diagrams summarize the frequencies of active caspase-8 + cancer cells, measured as triplicates of one of three representative experiments.

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) CD40L −/− and CD40 −/- mice were injected subcutaneously with 1 × 10 6 9.27 cancer cells. Summary of the tumor formation data obtained from two individual experiments, each with 6 to 10 mice per group. Tumor was defined as established when its volume reached >500 mm 3 . FSC-A, forward-scatter-area. ( B ) Cell surface expression of CD40 was analyzed after culturing 9.27 cancer cells, supplemented with or without TGFβ for 24 hours in three individual experiments. ( C and D ) The 9.27 cancer cells were treated for 24 hours with TGFβ and subsequently stimulated for further 24 hours with multimeric mouse CD40L. Thereafter, caspase-8 activity was determined with the fluorescence marker FITC-IETD-FMK and costained with annexin V. (C) The representative dot plots show the gating of annexin V and FITC-IETD-FMK–stained cancer cells after triggering CD40. (D) The diagrams summarize the frequencies of active caspase-8 + cancer cells, measured as triplicates of one of three representative experiments.

    Article Snippet: Subsequently, 5 × 10 4 cancer cells were plated in 96-well flat-bottom plates in phenol red–free DMEM supplemented with 1% FBS (Merck), penicillin (100 U/ml), and streptomycin (0.1 mg/ml; PAA) and cultured with or without human multimeric CD40L (10 μg/ml; Miltenyi Biotec) for 48 hours.

    Techniques: Injection, Expressing, Activity Assay, Fluorescence, Marker, Staining

    ( A ) Cell surface expression of CD40 was analyzed after culturing TRAMP-C1 and CD40 tg TRAMP-C1 cells with or without TGFβ for 24 hours. ( B ) Both TRAMP-C1 cancer cell lines were stimulated for 24 hours with multimeric CD40L. Thereafter, caspase-8 activity was determined with the fluorescence marker FITC-IETD-FMK. The representative dot plots show the gating of 4′,6-diamidino-2-phenylindole (DAPI) and FITC-IETD-FMK–stained cancer cells after triggering CD40. The diagrams summarize the frequencies of active caspase-8 + cancer cells. ( C and D ) E8I-Cre × CD40L fl/fl and E8I-Cre as WT control mice were injected subcutaneously with 5 × 10 6 TRAMP-C1 (C) or CD40 tg TRAMP-C1 (D) cancer cells. In the diagrams [(C) and (D)], the data from one of two representative experiments are shown. Per group, five or six mice were challenged. Tumor was defined as established when its volume reached >500 mm 3 . Statistical analysis: (B) Mann-Whitney U test: ** P < 0.01 and [(C) and (D)] log-rank test: * P < 0.05 and ** P < 0.01.

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) Cell surface expression of CD40 was analyzed after culturing TRAMP-C1 and CD40 tg TRAMP-C1 cells with or without TGFβ for 24 hours. ( B ) Both TRAMP-C1 cancer cell lines were stimulated for 24 hours with multimeric CD40L. Thereafter, caspase-8 activity was determined with the fluorescence marker FITC-IETD-FMK. The representative dot plots show the gating of 4′,6-diamidino-2-phenylindole (DAPI) and FITC-IETD-FMK–stained cancer cells after triggering CD40. The diagrams summarize the frequencies of active caspase-8 + cancer cells. ( C and D ) E8I-Cre × CD40L fl/fl and E8I-Cre as WT control mice were injected subcutaneously with 5 × 10 6 TRAMP-C1 (C) or CD40 tg TRAMP-C1 (D) cancer cells. In the diagrams [(C) and (D)], the data from one of two representative experiments are shown. Per group, five or six mice were challenged. Tumor was defined as established when its volume reached >500 mm 3 . Statistical analysis: (B) Mann-Whitney U test: ** P < 0.01 and [(C) and (D)] log-rank test: * P < 0.05 and ** P < 0.01.

    Article Snippet: Subsequently, 5 × 10 4 cancer cells were plated in 96-well flat-bottom plates in phenol red–free DMEM supplemented with 1% FBS (Merck), penicillin (100 U/ml), and streptomycin (0.1 mg/ml; PAA) and cultured with or without human multimeric CD40L (10 μg/ml; Miltenyi Biotec) for 48 hours.

    Techniques: Expressing, Activity Assay, Fluorescence, Marker, Staining, Control, Injection, MANN-WHITNEY

    ( A ) Histograms represent the CD40 expression on EJ138 or A704 transfected with nontargeting single guide RNA (black, sgNon) or cells depleted for CD40 by CRISPR-Cas9 and sgRNA against human CD40 (red). Gray-filled histograms show isotype staining. ( B ) sgNon (black) or caspase-8 sgRNA–treated (red) EJ138 and A704 cells were treated with multimeric CD40L for 24 hours, and caspase-8 activation was monitored by FITC-IETD-FMK staining. Gray-filled histograms represent the basal caspase-8 activation of unstimulated WT cells. ( C and D ) sgNon, CD40 sgRNA-, or caspase-8 (Casp8) sgRNA–treated variants of EJ138 (C) or A704 (D) were cocultivated with CD40L-enriched CD8 + T cells for 24 hours, and apoptosis was detected by annexin V and DAPI staining. Shown are representative dot plots with frequencies of technical triplicates (left) and bar graphs summarizing the data from experiments with eight different T cell donors. Statistical analysis: [(C) and (D)] Repeated measures ANOVA, followed by Dunnett’s test: ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) Histograms represent the CD40 expression on EJ138 or A704 transfected with nontargeting single guide RNA (black, sgNon) or cells depleted for CD40 by CRISPR-Cas9 and sgRNA against human CD40 (red). Gray-filled histograms show isotype staining. ( B ) sgNon (black) or caspase-8 sgRNA–treated (red) EJ138 and A704 cells were treated with multimeric CD40L for 24 hours, and caspase-8 activation was monitored by FITC-IETD-FMK staining. Gray-filled histograms represent the basal caspase-8 activation of unstimulated WT cells. ( C and D ) sgNon, CD40 sgRNA-, or caspase-8 (Casp8) sgRNA–treated variants of EJ138 (C) or A704 (D) were cocultivated with CD40L-enriched CD8 + T cells for 24 hours, and apoptosis was detected by annexin V and DAPI staining. Shown are representative dot plots with frequencies of technical triplicates (left) and bar graphs summarizing the data from experiments with eight different T cell donors. Statistical analysis: [(C) and (D)] Repeated measures ANOVA, followed by Dunnett’s test: ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Article Snippet: Subsequently, 5 × 10 4 cancer cells were plated in 96-well flat-bottom plates in phenol red–free DMEM supplemented with 1% FBS (Merck), penicillin (100 U/ml), and streptomycin (0.1 mg/ml; PAA) and cultured with or without human multimeric CD40L (10 μg/ml; Miltenyi Biotec) for 48 hours.

    Techniques: Expressing, Transfection, CRISPR, Staining, Activation Assay

    ( A ) In the histograms, the dark gray areas display the CD40 expression, and the light gray areas display the corresponding isotype control on eight different RCC lines. The included numbers represent the mean fluorescence intensity fold change between CD40 and isotype control staining. ( B ) Percentages of CD40L-induced lysis per RCC line after stimulation for 48 hours are plotted. Representative lysis values after backgorund substraction of each cell line of at least three individual experiments are depicted. ( C ) The heatmap represents the top 10 differentially expressed genes between CD40-resistant and CD40-sensitive RCC cell lines. ( D ) In the Kaplan-Meier survival plot, the resistance score of low and high groups of the TCGA-KIRC patient cohort is compared with each other. ( E ) Partial correlation networks of different patient groups are displayed, and the numbers are the partial correlation coefficients. ( F ) In the Kaplan-Meier survival plots, the resistance score of low and high groups of the cohorts is compared with all patients treated within the checkmate-009, checkmate-010, and checkmate-025 studies (left) or divided into two arms of the checkmate-025 study (middle nivolumab arm and right everolimus arm). Statistical analysis: (C) Described in Materials and Methods; [(D) and (F)] log-rank test.

    Journal: Science Advances

    Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

    doi: 10.1126/sciadv.adr9331

    Figure Lengend Snippet: ( A ) In the histograms, the dark gray areas display the CD40 expression, and the light gray areas display the corresponding isotype control on eight different RCC lines. The included numbers represent the mean fluorescence intensity fold change between CD40 and isotype control staining. ( B ) Percentages of CD40L-induced lysis per RCC line after stimulation for 48 hours are plotted. Representative lysis values after backgorund substraction of each cell line of at least three individual experiments are depicted. ( C ) The heatmap represents the top 10 differentially expressed genes between CD40-resistant and CD40-sensitive RCC cell lines. ( D ) In the Kaplan-Meier survival plot, the resistance score of low and high groups of the TCGA-KIRC patient cohort is compared with each other. ( E ) Partial correlation networks of different patient groups are displayed, and the numbers are the partial correlation coefficients. ( F ) In the Kaplan-Meier survival plots, the resistance score of low and high groups of the cohorts is compared with all patients treated within the checkmate-009, checkmate-010, and checkmate-025 studies (left) or divided into two arms of the checkmate-025 study (middle nivolumab arm and right everolimus arm). Statistical analysis: (C) Described in Materials and Methods; [(D) and (F)] log-rank test.

    Article Snippet: Subsequently, 5 × 10 4 cancer cells were plated in 96-well flat-bottom plates in phenol red–free DMEM supplemented with 1% FBS (Merck), penicillin (100 U/ml), and streptomycin (0.1 mg/ml; PAA) and cultured with or without human multimeric CD40L (10 μg/ml; Miltenyi Biotec) for 48 hours.

    Techniques: Expressing, Control, Fluorescence, Staining, Lysis